What ZIMMER BIOMET HOLDINGS, INC.'s SEC filings said
10 8-K filings. Each line is something a filing stated, ranked by score and linked to its source.
Ranked highest
- Guidance / Outlook62 · importance in its document · 8-K exhibit · 4 Nov 2026The company raised its 2026 organic constant-currency revenue-growth guidance to 3.0%–3.5% from 2.25%–3.25%, excluding the Paragon 28 acquisition impact through its April 2026 one-year anniversary. Updated constant-currency revenue-growth…
- Regulatory Risk57 · importance in its document · 8-K exhibit · 4 Nov 2026The European Union Medical Device Regulation adds premarket and postmarket requirements for medical devices, with transition deadlines extended to December 2027 or 2028 depending on the legacy device’s risk class. Zimmer Biomet reported…
- Guidance revised (direction not stated)55 · rule score among filings · 8-K Item 2.02 · 4 Nov 2026Company updates full-year 2026 financial guidance (WARSAW, IN) November 4, 2026 — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2026.
- Product Launch and Transition31 · importance in its document · 8-K exhibit · 8 Sept 2026Bradley Kessler will lead commercial strategy, growth and adoption for Zimmer Biomet’s robotics, digital and technology solutions in the Americas. The company plans to expand its specialized robotics salesforce ahead of the expected 2027…
- Strategic Initiatives31 · importance in its document · 8-K exhibit · 8 Sept 2026Zimmer Biomet announced leadership appointments intended to streamline its Americas and Global Business Group organizations and accelerate its U.S. go-to-market transformation. Effective October 1, Gary Campbell will become President,…
Ranked by score, 0–100. A topic read from a document carries its importance within that document; an 8-K event carries the rule score that ranks a filing among filings. Neither is about the share price, and the two scales are named on each row because they are not the same measure.
8-K filings last 12 months
- New debt12 Nov 2026 · 8-K Items 1.01, 2.03 · Routine · rule score 35“On November 5, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) entered into an underwriting agreement (the “EUR Underwriting Agreement”) with Barclays Bank PLC, Citigroup Global Markets Limited, HSBC Bank plc, Morgan Stanley & Co.…”
- Guidance revised (direction not stated)4 Nov 2026 · 8-K Item 2.02 · Flagged · rule score 55“Company updates full-year 2026 financial guidance (WARSAW, IN) November 4, 2026 — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2026.”
- Management change (filing not read)8 Sept 2026 · 8-K Item 5.02 · Routine · rule score 20Read from the attached exhibit: Product Launch and Transition · Strategic Initiatives · Guidance / Outlook
- Press release attached to an 8-K5 Aug 2026 · 8-KRead from the attached exhibit: Contingent Consideration Liability · Inventory Cost Pressure · Outstanding Indebtedness
- Results (release not read)5 Aug 2026 · 8-K Item 2.02 · Routine · rule score 20Read from the attached exhibit: Geographic Market Commentary · Operating Expense Trends · Operating Cash Flow Trends
- New debt29 Jun 2026 · 8-K Items 1.01, 2.03 · Routine · rule score 25
- Management change (filing not read)28 Apr 2026 · 8-K Item 5.02 · Routine · rule score 20
- Results (release not read)28 Apr 2026 · 8-K Item 2.02 · Routine · rule score 20
- Results (release not read)10 Feb 2026 · 8-K Item 2.02 · Routine · rule score 20
- Management change (filing not read)12 Jan 2026 · 8-K Item 5.02 · Routine · rule score 20
Topics are read from the text of the 10-K, 10-Q or the exhibit attached to an 8-K, each linked to the passage it came from. 8-K events are labelled by fixed rules from the item codes and the filing text — the same rules for every company and every year. The Full Picture merges these with earnings calls and news.